LRMR Insider Trading - Larimar Therapeutics, Inc.

Jumlah Saham Beredar	85,590,392 shares
Saham Orang Dalam	22,896,118 shares
Kepemilikan oleh Orang Dalam	26.75 %
Orang Dalam Sejati	47

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

1 ( )

351 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

21.731 %( )

6 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Larimar Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Patricia L Allen Chief Financial Officer - [O]	19,793	19,793
Atlas Venture Associates VII, Inc. 10% Owner - [10%]	11	11
Atlas Venture Associates VII, L.P. 10% Owner - [10%]	11	11
Atlas Venture Fund VII L P 10% Owner - [10%]	11	11
Carole Ben-maimon President and CEO, Director - [D] [O]	387,208	387,208
Peter Barrett Director, 10% Owner - [D] [10%]	4,643,327	4,643,327
Bruce Booth Director, 10% Owner - [D] [10%]	4,638,028	4,638,028
Chondrial Therapeutics Holdings, Llc 10% Owner - [10%]	8	8
Michael Celano Chief Financial Officer - [O]	178,181	178,181
Russell Clayton Chief Medical Officer - [O]	45,806	45,806
Management Co Deerfield 10% Owner - [10%]	8,300	11,529,111
Deerfield Partners, L.p. 10% Owner - [10%]	5,555,554	11,529,111
Thomas O Daniel Director - [D]	19,452	19,452
Deerfield Healthcare Innovations Fund, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield International Master Fund, L.P. 10% Owner - [10%]	1,151,802	1,151,802

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Deerfield Mgmt HIF, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield Mgmt III, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield Mgmt IV, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield Mgmt L.P. 10% Owner - [10%]	1,151,802	11,529,111
Deerfield Private Design Fund III, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield Private Design Fund IV, L.P. Director, 10% Owner - [D] [10%]	1,943,420	11,529,111
Deerfield Special Situations Fund, L.P. 10% Owner - [10%]	1,151,802	1,151,802
Wendy Everett	27,000
James E Flynn Director, 10% Owner - [D] [10%]	11,529,111	11,529,111
Goldberg Avi Y. Director - [D]	53,734	53,734
Thomas Edward Hamilton Director - [D]	724,231	724,231
Hatfield Jeffrey S.	525,000
Frances K Heller Director - [D]	47,961	47,961
Hughes Thomas E. See Remarks, Director - [D] [O]	125,247	125,247
Dennis D Kim Chief Medical Officer - [O]	21,443	21,443
John L Lamattina Director - [D]	31,376	31,376

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Jonathan S Leff	8,300
Mark J Levin 10% Owner - [10%]	0	0
Patrick Loustau	56,500
Cameron Geoffrey McDonough Director - [D]	0	0
Brian McVeigh	125,000
Robert J Perez Director - [D]	5,322	5,322
Kevin P Starr Director - [D]	370,323	370,323
Alicia Secor Chief Commercial Officer - [O]	0	0
Gopi Shankar Chief Development Officer - [O]	50,806	50,806
Priya Singhal	375,000
Robert I Tepper 10% Owner - [10%]	0	0
Third Rock Ventures Lp 10% Owner - [10%]	0	0
Frank E Thomas Director - [D]	2,000	2,000
Trv Gp, Llc 10% Owner - [10%]	0	0
Third Rock Ventures GP, L.P. 10% Owner - [10%]	0	0
Joseph Truitt Director - [D]	2,750	2,750

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di LRMR / Larimar Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2025-07-31	Flynn James E	2,599,932	3.2000	2,599,932	3.2000	8,319,782	14	4.2600	2,755,928	33.13
2025-07-31	Flynn James E	3,387,539	3.2000	3,387,539	3.2000	10,840,125
2025-07-31	Flynn James E	3,387,529	3.2000	3,387,529	3.2000	10,840,093
2024-02-16	Flynn James E	1,430,205	8.7400	1,430,205	8.7400	12,499,992
2024-02-16	Flynn James E	1,430,206	8.7400	1,430,206	8.7400	12,500,000
2024-02-16	Flynn James E	1,430,206	8.7400	1,430,206	8.7400	12,500,000
2024-02-16	Hamilton Thomas Edward	57,208	8.7400	57,208	8.7400	499,998
2024-02-14	THOMAS FRANK E	2,000	11.0000	2,000	11.0000	22,000
2023-12-07	Shankar Gopi	5,000	3.7323	5,000	3.7323	18,662

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

LRMR / Larimar Therapeutics, Inc. Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di LRMR / Larimar Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit
2016-07-20	Flynn James E	901,430	3.3118	901,430	3.3118	2,985,356	8
2016-07-20	Flynn James E	246,439	3.3118	246,439	3.3118	816,157
2016-07-20	Flynn James E	193,630	3.3118	193,630	3.3118	641,264
2015-09-24	STARR KEVIN P	61,630	44.1000	61,630	44.1000	2,717,883
2015-09-24	STARR KEVIN P	74,949	43.7300	74,949	43.7300	3,277,520
2015-09-17	KIM DENNIS D	9,142	40.0000	9,142	40.0000	365,680
2015-09-15	KIM DENNIS D	30,265	40.0000	30,265	40.0000	1,210,600
2015-09-14	KIM DENNIS D	593	40.0000	593	40.0000	23,720

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3.2000	2,599,932	8,320		7,321,129
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3.2000	3,387,539	10,840		9,538,945
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3.2000	3,387,529	10,840		9,538,918
2025-01-24	2025-01-22	4	Clayton Russell	LRMR	Common Stock	A - Award	D			23,306			45,806
2025-01-24	2025-01-22	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			23,306			50,806
2025-01-24	2025-01-22	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			91,000			387,208
2025-01-24	2025-01-22	4	Celano Michael	LRMR	Common Stock	A - Award	D			34,185			178,181
2024-05-31	2024-02-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8.7400	57,208	500		564,798
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		8.7400	1,430,205	12,500		4,207,982
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8.7400	1,430,206	12,500		6,151,406
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8.7400	1,430,206	12,500		6,151,406
2024-02-15	2024-02-14	4	THOMAS FRANK E	LRMR	Common Stock	P - Purchase	D		11.0000	2,000	22		2,000
2024-01-19	2024-01-17	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			22,500			27,500
2024-01-19	2024-01-17	4	Celano Michael	LRMR	Common Stock	A - Award	D			31,250			143,996
2024-01-19	2024-01-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			66,125			332,954
2024-01-19	2024-01-17	4	Clayton Russell	LRMR	Common Stock	A - Award	D			22,500			22,500
2023-12-08	2023-12-07	4	Shankar Gopi	LRMR	Common Stock	P - Purchase	D		3.7323	5,000	19		5,000
2023-05-18	2023-05-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3.7050	5,000	19		266,829
2023-05-18	2023-05-17	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3.7263	5,000	19		112,746
2023-05-18	2023-05-17	4	Truitt Joseph	LRMR	Common Stock	P - Purchase	D		3.7300	2,750	10		2,750
2023-02-02	2023-01-31	4	Celano Michael	LRMR	Common Stock	A - Award	D			76,000			107,746
2023-02-02	2023-01-31	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			205,000			261,829
2022-09-20		3	Deerfield Mgmt L.P.	LRMR	Common Stock		D						2,777,777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		3.1500	2,777,777	8,750		2,777,777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3.1500	2,777,777	8,750		2,777,777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3.1500	2,777,777	8,750		2,777,777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3.1500	2,777,777	8,750		2,777,777
2022-09-20	2022-09-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		3.1500	317,460	1,000		507,590
2022-09-19	2022-09-16	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3.1500	31,746	100		56,829
2022-09-19	2022-09-16	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3.1500	31,746	100		31,746
2022-05-12	2022-05-10	4	Truitt Joseph	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		8,300		8,300
2022-05-12	2022-05-10	4	LEFF JONATHAN S	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		8,300		8,300
2022-05-12	2022-05-10	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		20,000		20,000
2022-05-12	2022-05-10	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		40,000		40,000
2022-05-12	2022-05-10	4	THOMAS FRANK E	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		8,300		8,300
2022-05-12	2022-05-10	4	Barrett Peter	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		8,300		8,300
2022-05-12	2022-05-10	4	Hamilton Thomas Edward	LRMR	Stock Option (Right to Buy)	A - Award	D	2.92		8,300		8,300
2022-05-11	2022-05-10	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	2.92		8,300		8,300
2022-01-20	2022-01-18	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	8.75		80,000		80,000
2022-01-20	2022-01-18	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	8.75		182,000		182,000
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		8.7500	228,570	2,000		1,943,420
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8.7500	228,571	2,000		1,943,423
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8.7500	228,569	2,000		1,943,406
2021-07-02	2021-06-30	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8.7500	56,710	496		190,130
2021-05-20	2021-05-12	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	10.34		8,300		8,300
2021-05-17	2021-05-12	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	10.34		8,300		8,300
2021-01-21	2021-01-19	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	19.61		106,700		106,700
2021-01-21	2021-01-19	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	19.61		42,000		42,000
2020-10-01	2020-09-29	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	11.90		16,600		16,600
2020-09-30	2020-09-29	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	Celano Michael	LRMR	Stock Option (right to buy)	A - Award	D	11.90		84,100		84,100
2020-09-30	2020-09-29	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	11.90		16,600		16,600
2020-09-30	2020-09-29	4	BEN-MAIMON CAROLE	LRMR	Stock Option (right to buy)	A - Award	D	11.90		411,400		411,400
2020-06-30	2020-06-26	4	BEN-MAIMON CAROLE	LRMR	Common Stock	J - Other	D			25,083			25,083
2020-06-30	2020-06-26	4	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock	J - Other	D			-6,091,242			8
2020-06-30	2020-06-26	4	Hamilton Thomas Edward FA Life Sciences, Inc.	LRMR	Common Stock	J - Other	I			159,433			292,853
2020-06-30	2020-06-26	4	Hamilton Thomas Edward	LRMR	Common Stock	J - Other	D			133,420			133,420
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12,182,500
2020-06-05	2020-05-28	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	11.88		60,479		60,479
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12,182,500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12,182,500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12,182,500
2019-06-27	2019-06-26	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-06-27	2019-06-26	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	1.25		27,000		27,000
2019-04-04	2019-04-02	4	Singhal Priya	ZFGN	Stock Option (Right to Buy)	A - Award	D	2.89		375,000		375,000
2019-01-28	2019-01-24	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.38		21,396		21,396
2019-01-28	2019-01-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.38		11,804		11,804
2019-01-28	2019-01-24	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.38		13,280		13,280
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.38		5,717		5,717
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		4.3800	4,423	19		5,322
2019-01-28	2019-01-24	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4.3800	10,844	47		31,376
2019-01-24	2019-01-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.63		125,000		125,000
2019-01-24	2019-01-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.63		95,000		95,000
2019-01-24	2019-01-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.63		525,000		525,000
2019-01-24	2019-01-22	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.63		125,000		125,000
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-234,321			11
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1,126,546			3,506,184
2018-06-29	2018-06-28	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10.0000	-32,000	-320		125,247
2018-06-07	2018-06-06	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		40,000		40,000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.79		20,000		20,000
2018-05-30	2018-05-29	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.46		225,000		225,000
2018-03-09	2018-03-07	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10.0000	-5,000	-50		157,247
2018-02-23	2018-02-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7.77		125,000		125,000
2018-02-23	2018-02-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	7.77		275,000		275,000
2018-02-23	2018-02-22	4	Hughes Thomas E.	ZFGN	Stock Option (right to buy)	A - Award	D	7.77		275,000		275,000
2018-02-23	2018-02-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	7.77		125,000		125,000
2018-01-05	2018-01-03	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.18		9,421		9,421
2018-01-05	2018-01-03	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.18		9,725		9,725
2018-01-05	2018-01-03	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.18		8,509		8,509
2018-01-05	2018-01-03	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.18		17,627		17,627
2018-01-05	2018-01-03	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		5.1800	9,169	47		20,532
2018-01-05	2018-01-03	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		5.1800	8,687	45		19,452
2017-12-29	2017-12-29	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.40		1,100,000		1,100,000
2017-10-17	2017-10-13	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3.8988	10,000	39		47,961
2017-10-11	2017-10-09	4	Hughes Thomas E.	ZFGN	Employee Stock Option (right to buy)	A - Award	D	3.40		275,000		275,000
2017-10-11	2017-10-09	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.40		550,000		550,000
2017-07-12	2017-07-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		3.3900	10,000	34		21,443
2017-06-23	2017-06-21	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-06-23	2017-06-21	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	3.95		14,500		14,500
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0.82		-68,073		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0.75		-6,210		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy	M - Exercise	D	0.75		-18,928		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.8200	68,073	56		157,371
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.7500	6,210	5		89,298
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.7500	18,928	14		83,088
2017-05-11	2017-05-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4.4000	9,800	43		11,443
2017-05-11	2017-05-10	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4.4000	200	1		1,643
2017-02-14	2017-02-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.18		12,003		12,003
2017-02-14	2017-02-13	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.18		13,718		13,718
2017-02-14	2017-02-13	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		4.1800	10,765	45		10,765
2017-02-14	2017-02-13	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.18		13,289		13,289
2017-02-14	2017-02-13	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4.1800	11,363	47		11,363
2017-02-14	2017-02-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.18		24,864		24,864
2017-01-31	2017-01-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.05		88,000		88,000
2017-01-31	2017-01-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.05		88,000		88,000
2017-01-31	2017-01-27	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4.05		319,000		319,000
2016-12-20	2016-12-19	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3.2290	10,000	32		30,000
2016-11-17	2016-11-15	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3.5434	10,000	35		20,000
2016-08-31	2016-08-29	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		2.9987	10,000	30		63,936
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3.3118	-901,430	-2,985		1,151,802
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3.3118	-246,439	-816		314,889
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	S - Sale	I		3.3118	-193,630	-641		247,413
2016-07-26	2016-07-26	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3.1500	8,200	26		19,793
2016-07-26	2016-07-25	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3.0810	7,800	24		11,593
2016-07-26	2016-07-22	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		2.9900	10,000	30		10,000
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0.75		25,000		18,928
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		3.0208	5,000	15		53,936
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.7500	25,000	19		48,936
2016-07-01	2016-06-30	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-07-01	2016-06-30	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5.99		12,000		12,000
2016-04-12	2016-01-07	4	PEREZ ROBERT J See note	ZFGN	Common Stock	A - Award	I		6.2900	5,564	35		5,564
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		36,000		36,000
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		72,000		72,000
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		37,500		37,500
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		75,000		75,000
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.70		3,841		3,841
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.70		24,000		24,000
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	7.91		6,100		6,100
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	D - Sale to Issuer	D		7.9100	-4,424	-35		0
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		-26,500		26,500
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		-53,000		53,000
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		56,500		56,500
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		113,000		113,000
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		124,500		124,500
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6.68		249,000		249,000
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2466	13,872	87		2,053,232
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2466	28,377	177		561,328
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2466	22,296	139		441,043
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4,705,436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3,049,910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3,138,914
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.1884	504	3		2,039,360
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.1884	1,030	6		532,951
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6.1884	810	5		418,747
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2323	32,501	203		2,038,856
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2323	66,486	414		531,921
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6.2323	52,239	326		417,937
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5.7291	24,484	140		2,006,355
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5.7291	50,086	287		465,435
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		5.7291	39,353	225		365,698
2016-01-27	2016-01-25	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		7.9100	8,849	70		4,643,327
2016-01-27	2016-01-25	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	A - Award	D		7.9100	4,424	35		4,424
2016-01-27	2016-01-25	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		7.9100	4,424	35		4,638,028
2016-01-27	2016-01-25	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7.91		9,150		9,150
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0.75		-10,000		43,928
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.7500	10,000	8		21,320
2015-10-30	2015-10-28	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		10.4500	899	9		899
2015-10-30	2015-10-28	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	10.45		1,207		1,207
2015-10-20	2015-09-14	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-593	-24		0
2015-10-20	2015-09-17	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-9,142	-366		0
2015-10-20	2015-09-15	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-30,265	-1,211		0
2015-09-28	2015-09-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	40.56		24,000		24,000
2015-09-28	2015-09-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	40.56		24,000		24,000
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			98,834			370,323
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-476,170			0
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			476,170			476,170
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		44.1000	-61,630	-2,718		210,371
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		43.7300	-74,949	-3,278		272,001
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1,655,095			346,950
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0.75		-10,500		53,928
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0.7500	10,500	8		11,320
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2.45		-23,126		160,555
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		45.0000	-23,126	-1,041		820
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2.4500	23,126	57		23,946
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2.45		-4,874		183,681
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		40.0000	-22,500	-900		820
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2.4500	4,874	12		23,320
2015-09-21	2015-09-18	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		45.0000	-5,000	-225		53,734
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	9.67		-25,000		134,235
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41.0500	-1,256	-52		0
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41.0500	-25,000	-1,026		1,256
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	M - Exercise	D		9.6700	25,000	242		26,256
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1.57		-9,142		103,312
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-9,142	-366		0
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1.5700	9,142	14		9,142
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1.57		-30,265		112,454
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-30,265	-1,211		0
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1.5700	30,265	48		30,265
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1.57		-593		142,719
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40.0000	-593	-24		0
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1.5700	593	1		593
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			99,351			271,489
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-479,081			0
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			479,081			479,081
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1,200,000			2,002,045
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-479,081			0
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			479,081			479,081
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1,200,000			2,002,045
2015-07-15	2015-07-13	4	STARR KEVIN P	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	Goldberg Avi Y.	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-07-15	2015-07-13	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	37.15		12,000		12,000
2015-06-12	2015-06-10	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		35.0000	-3,000	-105		58,734
2015-06-03	2015-06-01	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		32.2262	-2,000	-64		61,734
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			92,041			172,138
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-443,935			0
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			443,935			443,935
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1,000,000			3,202,045
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-443,935			0
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			443,935			443,935
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1,000,000			3,202,045
2015-03-26	2015-03-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1,000,000			4,632,730
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			71,989			80,097
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-346,658			0
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			346,658			346,658
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1,400,000			4,202,045
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-346,658			0
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			346,658			346,658
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1,400,000			4,202,045
2015-03-19	2015-03-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	45.57		180,000		180,000
2015-03-03	2015-02-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	38.65		60,000		187,388
2015-03-03	2015-02-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	38.65		90,000		281,509
2015-03-03	2015-02-27	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	38.65		60,000		219,235
2015-03-03	2015-02-27	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	38.65		45,000		324,777
2015-01-12	2015-01-08	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		40.0400	874	35		5,633,604
2015-01-12	2015-01-08	4	STARR KEVIN P	ZFGN	Common Stock	A - Award	D		40.0400	1,248	50		9,356
2015-01-12	2015-01-08	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		40.0400	1,748	70		5,634,478
2015-01-12	2015-01-08	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	40.04		1,593		9,554
2014-11-03	2014-10-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	21.34		13,327		13,327
2014-06-26	2014-06-24	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	16.00		13,327		13,327
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series D Preferred Stock	C - Conversion	I			-4,666,478		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series C Preferred Stock	C - Conversion	I			-8,263,595		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series B Preferred Stock	C - Conversion	I			-22,250,770		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			743,070			5,610,153
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			1,315,859			4,867,083
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			3,543,116			3,551,224
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series D Preferred Stock	C - Conversion	I			-4,690,696		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series C Preferred Stock	C - Conversion	I			-8,263,595		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series B Preferred Stock	C - Conversion	I			-17,651,253		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series A Preferred Stock	C - Conversion	I			-4,768,001		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			746,926			5,632,730
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			1,315,859			4,885,804
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			2,810,709			3,569,945
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			759,236			759,236
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series D Preferred Stock	C - Conversion	D			-4,690,696		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series C Preferred Stock	C - Conversion	D			-8,263,595		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series B Preferred Stock	C - Conversion	D			-17,651,253		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series A Preferred Stock	C - Conversion	D			-4,768,001		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			746,926			5,632,730
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			1,315,859			4,885,804
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			2,810,709			3,569,945
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			759,236			759,236
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series D Preferred Stock	C - Conversion	I			-4,690,696		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series C Preferred Stock	C - Conversion	I			-8,263,595		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series B Preferred Stock	C - Conversion	I			-17,651,253		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series A Preferred Stock	C - Conversion	I			-4,768,001		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			746,926			5,632,730
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			1,315,859			4,885,804
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			2,810,709			3,569,945
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			759,236			759,236
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series D Preferred Stock	C - Conversion	D			-4,666,478		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series C Preferred Stock	C - Conversion	D			-8,263,595		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series B Preferred Stock	C - Conversion	D			-22,250,770		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			743,070			5,602,045
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			1,315,859			4,858,975
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			3,543,116			3,543,116
2014-06-26	2014-06-24	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	16.00		279,777		279,777
2014-06-23	2014-06-19	4	Secor Alicia Held by Spouse	ZFGN	Common Stock	P - Purchase	I		20.0000	4,000	80		4,000
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16,216
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16,216
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70,506
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70,506
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695,284
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695,284

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

LRMR / Larimar Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5